Overview

Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone.

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
0
Participant gender:
Male
Summary
The general hypothesis put forward in this study is that the degree of cohesion (agreement) in the relationship, or dyadic adjustment affects a patient's quality of life and clinical course during the first few critical months following diagnosis and the introduction of treatment. The level of cohesion in the relationship is certainly not the only parameter associated with changes in the quality of life. Other factors must also be investigated such as level of education, circumstances surrounding the diagnosis (new diagnosis or relapse), management (single therapy or adjuvant therapy), the level of physical activity, the patient's age and the presence of functional disorders, etc.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ipsen
Treatments:
Hormones
Criteria
Inclusion Criteria:

- Patient presenting with histologically confirmed prostate cancer.

- Patient eligible to start GnRH agonist therapy, either as monotherapy or adjuvant
therapy, and for whom one of these treatments was selected voluntarily by the
urologist, prior to the start of the study.

- Patient currently living with the same partner for at least 6 months.

- Patient and partner capable of reading, understanding and returning an evaluation
self-questionnaire 6 months after the initial consultation.

- Patient giving its written consent to participate to the study.

Exclusion Criteria:

- The subject is participating in another clinical trial.

- Patient who has received a GnRH agonist therapy during the last 2 years.